 | • レポートコード：B-MOR-08028 • 出版社/出版日：Mordor Intelligence / 2018年5月24日 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（受注後2営業日） • 産業分類：Healthcare |
| Single User（1名様用） | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User（7名様用） | ￥666,000 (USD4,500) | ▷ お問い合わせ |
| Corporate User | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、羊水穿刺針の世界市場について調べ、羊水穿刺針の世界規模、市場動向、市場環境、タイプ別（100〜150mmの針、150mm以上の針、100mm未満の針）分析、処置別（羊水穿刺、羊水除去、胎児の輸血、羊水注入、臍帯穿刺）分析、エンドユーザー別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、企業の競争環境、関連企業情報などをまとめた調査レポートです。 ・イントロダクション ・エグゼクティブサマリー ・羊水穿刺針の世界市場インサイト ・羊水穿刺針の世界市場環境 ・羊水穿刺針の世界市場動向 ・羊水穿刺針の世界市場規模 ・羊水穿刺針の世界市場規模：タイプ別（100〜150mmの針、150mm以上の針、100mm未満の針） ・羊水穿刺針の世界市場規模：処置別（羊水穿刺、羊水除去、胎児の輸血、羊水注入、臍帯穿刺） ・羊水穿刺針の世界市場規模：エンドユーザー別 ・羊水穿刺針の世界市場：地域別市場規模・分析 ・羊水穿刺針の北米市場規模・予測 ・羊水穿刺針のアメリカ市場規模・予測 ・羊水穿刺針のヨーロッパ市場規模・予測 ・羊水穿刺針のアジア市場規模・予測 ・羊水穿刺針のインド市場規模・予測 ・羊水穿刺針の韓国市場規模・予測 ・関連企業情報・競争状況 |
The global amniocentesis needle market is expected to register a CAGR of about 5.4% over the forecast period, 2018-2023. Amniocentesis is a procedure that is used for the diagnosis of fetal defects in the second trimester of pregnancy. A sample from the amniotic fluid, surrounding the fetus in the womb, is collected through a pregnant woman’s abdomen using a needle and syringe.
High Reliability of Amniocentesis
Amniocentesis is 99.4% accurate. This test determines if the baby in the womb has any genetic or chromosomal abnormalities. The test can identify many genetic disorders, such as Down syndrome, Edward’s syndrome, Tay-Sachs disease, Huntington’s disease, Sickle cell disease, and cystic fibrosis. Other testing techniques, like ultrasounds, pick up on the genetic defects or problems that might be there in the fetus. However, only amniocentesis can provide the information needed to diagnosis these complications in the fetus. Due to the high reliability of the test, this market is expected to expand during the forecast period. Other factors, such as, the growth in the median age of first-time motherhood and heavy burden of congenital disorders are also expected to drive the market studied.
Availability of Alternate Methods
Amniocentesis is an invasive procedure where a needle in inserted into the womb of the mother for the collection of amniotic fluid, in order to study the possibility of prenatal disorders. Although Amniocentesis is a fairly safe procedure, there are occasional cases where it may lead to miscarriages, as the procedure involves invasive methods. Due to this, many pregnant women prefer the usage of alternative testing options, such as noninvasive prenatal test (NIPT), first trimester combined screening, second trimester quad screen, and integrated screening, among others. This is expected to slow down the growth of the amniocentesis needle market.
North America to Maintain Lead in the Market
The global amniocentesis needle market is dominated by North America and Europe respectively. North America will continue to dominate the global market during the forecast period. Factors, such as the rising government initiatives and increasing healthcare expenditure, are driving the growth of the market in this region.
Key Developments:
• March 2018 – A team of researchers led by Brock A. Peters, PhD, of Complete Genomics in San Jose, California, have shown that amniocentesis linked with whole-genome sequencing (WGS) can be used to analyze a fetus’ entire genome for harmful mutations. Peters’ team collected amniotic fluid from 31 pregnant women and isolated DNA from both the amniotic fluid and the fetal cells within it.
Major Players: BECTON, DICKINSON AND COMPANY, BIOPSYBELL, COOK MEDICAL, COOPERSURGICAL, INTEGRA LIFESCIENCES, LABORATOIRE CCD, MEDLINE, MEDTRONIC, RI.MOS., ROCKET MEDICALAND SMITHS MEDICAL, TSUNAMI MEDICAL, amongst others.
Reasons to Purchase the Report
• Current and future amniocentesis needle market outlook in the developed and emerging markets
• Analysis of various perspectives of the market with the help of Porter’s five forces analysis
• The segment that is expected to dominate the market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, market shares, and strategies employed by the major market players
• 3 months analyst support, along with the Market Estimate sheet (in Excel)
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs.
レポート目次1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter’s Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Competitive Rivalry Within the Industry
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Drivers
6.1.1 High Reliability of Amniocentesis
6.1.2 Growing Median Age of First-Time Motherhood
6.1.3 Increasing Burden of Congenital Disorders
6.2 Restraints
6.2.1 Availability of Alternate Methods
6.3 Opportunities
6.4 Key Challenges
7. Market Segmentation
7.1 By Type
7.1.1 100–150 mm Needles
7.1.2 Larger Than 150 mm Needles
7.1.3 Smaller Than 100 mm Needles
7.2 By Procedure
7.2.1 Amniocentesis Procedures
7.2.2 Amnioreduction Procedures
7.2.3 Fetal Blood Transfusion Procedures
7.2.4 Amnioinfusion Procedures
7.2.5 Cordocentesis Procedures
7.3 By End User
7.3.1 Hospitals
7.3.2 Diagnostic Centers
7.3.3 Clinics
7.3.4 Other End Users
7.4 By Geography
7.4.1 North America
7.4.1.1 United States
7.4.1.2 Canada
7.4.1.3 Mexico
7.4.2 Europe
7.4.2.1 France
7.4.2.2 Germany
7.4.2.3 United kingdom
7.4.2.4 Italy
7.4.2.5 Spain
7.4.2.6 Rest of Europe
7.4.3 Asia-Pacific
7.4.3.1 India
7.4.3.2 Australia & New Zealand
7.4.3.3 South korea
7.4.3.4 Rest of Asia-Pacific
7.4.4 Rest of the World
7.4.4.1 Saudi Arabia
7.4.4.2 Brazil
7.4.4.3 Others
8. Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9. Key Players
9.1 Becton, Dickinson and Company
9.2 Biopsybell
9.3 Cook Medical
9.4 Coopersurgical
9.5 Integra Lifesciences
9.6 Laboratoire Ccd
9.7 Medline
9.8 Medtronic
9.9 Ri.Mos.
9.10 Rocket Medical
9.11 Smiths Medical
9.12 Tsunami Medical
*List not Exhaustive
10. Future of the Market